West Pharma (WST) Reports In-Line Q4 EPS; Issues Lightish FY14 Profit Outlook

February 20, 2014 7:20 AM

West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.38, in-line with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found